Ulcerative Colitis
📧 Sign up to get email alerts when something new happens for Ulcerative Colitis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2017-07-27FDA Approved: LIALDA — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for LIALDA (mesalamine) submitted by Takeda Pharmaceuticals America, Inc.
-
CLINICAL_TRIALS trial_result · 2017-07-26Clinical Trial Update: Budesonide 9 mg Capsules in Active UC [Phase 2]
A Phase 2 trial evaluating budesonide 9 mg capsules for active ulcerative colitis has completed.
-
FDA approval · 2017-07-21FDA Approved: MESALAMINE — Original Application (Zydus Lifesciences Limited)
FDA approves the original application for MESALAMINE from Zydus Lifesciences Limited for the treatment of ulcerative colitis.
-
CLINICAL_TRIALS research · 2017-07-19Clinical Trial Update: Individualized Infiximab Dosing-Proof of Concept Study
A clinical trial update for a proof-of-concept study on individualized dosing of infliximab in inflammatory bowel diseases. The sponsor is C…
-
CLINICAL_TRIALS trial_result · 2017-07-19Clinical Trial Update: Self-Management Assistance for Recommended Treatment (SMART) Portal
The SMART Portal clinical trial, sponsored by Cincinnati Children's Hospital Medical Center, has completed and evaluated a self-management p…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-07-07Clinical Trial Update: A First Time In Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of GSK1399686 [Phase 1]
This first-in-human Phase 1 trial evaluates the safety, tolerability, and pharmacokinetics of GSK1399686 in inflammatory bowel diseases and …
-
CLINICAL_TRIALS trial_result · 2017-07-07Clinical Trial Update: Phase 2a Study to Evaluate the Safety/Tolerability and Efficacy of TOP1288 200 mg Rectal Solution Once Daily for 4 Weeks in Ulcerative Colitis [Phase 2]
A Phase 2a trial evaluating the safety, tolerability, and efficacy of TOP1288 200 mg rectal solution once daily for 4 weeks in Ulcerative Co…
-
CLINICAL_TRIALS trial_result · 2017-07-06Clinical Trial Update: Interest of Propionibacterium Freudenreichii for the Treatment of Mild to Moderate Ulcerative Colitis [NA]
A clinical trial evaluating the probiotic Propionibacterium freudenreichii for mild to moderate ulcerative colitis has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-06-26Clinical Trial Update: Effect of GSK1399686 in Patients With Mild to Moderately Active Ulcerative Colitis [Phase 2]
Phase 2 trial results for GSK1399686 in mild to moderately active ulcerative colitis have been posted after completion.
-
FDA approval · 2017-06-22FDA Approved: SIMPONI — Supplemental Application (Janssen Biotech, Inc.)
FDA approved a supplemental application for Simponi (golimumab) submitted by Janssen Biotech, Inc.
-
CLINICAL_TRIALS trial_result · 2017-06-16Clinical Trial Update: Granulocyte-monocyte Apheresis in Ulcerative Colitis [NA]
This clinical trial update confirms the completion of a study evaluating granulocyte-monocyte apheresis for ulcerative colitis (NCT03189888)…
-
CLINICAL_TRIALS trial_result · 2017-06-15Clinical Trial Update: Propionyl-L-Carnitine in Ulcerative Colitis [Phase 2]
Phase 2 clinical trial of Propionyl-L-Carnitine for Ulcerative Colitis has completed.
-
CLINICAL_TRIALS trial_result · 2017-06-15Clinical Trial Update: A Study to Investigate the Safety and Efficacy of LT-02 in Patients With Mesalamine Refractory Ulcerative Colitis (UC) [Phase 3]
A Phase 3 study of LT-02 for mesalamine-refractory ulcerative colitis has been terminated, with the study status recorded as TERMINATED.
-
CLINICAL_TRIALS trial_result · 2017-06-14Clinical Trial Update: Oral OKT3 for the Treatment of Active Ulcerative Colitis [Phase 1, Phase 2]
Results from a Phase 1/2 clinical trial evaluating oral muromonab-CD3 (OKT3) for active ulcerative colitis; the study has completed and resu…
-
FDA approval · 2017-06-05FDA Approved: MESALAMINE — Original Application (Zydus Lifesciences Limited)
FDA approved the original application for mesalamine from Zydus Lifesciences Limited, confirming the generic product for inflammatory bowel …
-
CLINICAL_TRIALS trial_result · 2017-06-01Clinical Trial Update: A Phase 1b Study to Assess the Safety and Anti-inflammatory Effects of Two Different Doses of SRT2104 in Patients With Ulcerative Colitis [Phase 1]
A Phase 1b study evaluated the safety and anti-inflammatory effects of two doses of SRT2104 in patients with Ulcerative Colitis, and the tri…
-
CLINICAL_TRIALS trial_result · 2017-05-31Clinical Trial Update: Detection of Helicobacter Pylori in Ulcerative Colitis Patients [NA]
This clinical trial update examines detection of Helicobacter pylori in patients with ulcerative colitis; the current status of the trial is…
-
CLINICAL_TRIALS trial_result · 2017-05-23Clinical Trial Update: Study for Safety and Tolerability of TOP1288 Administered Rectally in Healthy and Ulcerative Colitis Subjects [Phase 1]
Phase 1 study evaluating safety and tolerability of TOP1288 administered rectally in healthy subjects and patients with Ulcerative Colitis; …
-
CLINICAL_TRIALS trial_result · 2017-05-18Clinical Trial Update: A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis [Phase 3]
Phase 3 trial results for oral tofacitinib (CP-690,550) as maintenance therapy in ulcerative colitis were completed and results were posted …
-
CLINICAL_TRIALS trial_result · 2017-05-12Clinical Trial Update: Two Therapeutic Strategies for the Maintenance of Remission in Patients With Ulcerative Colitis [Phase 4]
This Phase 4 clinical trial update reports two therapeutic strategies being evaluated to maintain remission in patients with ulcerative coli…
-
CLINICAL_TRIALS research · 2017-05-12Clinical Trial Update: The Diversity of the Fungal and Bacterial in Colon Mucosa of Patients With Different Degree of Inflammation of Ulcerative Colitis
This clinical trial update reports on the diversity of fungal and bacterial communities in the colon mucosa of ulcerative colitis patients w…
-
CLINICAL_TRIALS research · 2017-05-10Clinical Trial Update: Randomized Controlled Trial of Stress Reduction and Lifestyle Modification for Ulcerative Colitis [NA]
A randomized trial in Ulcerative Colitis evaluating stress reduction and lifestyle modification; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2017-05-04Clinical Trial Update: Head-to-head Comparison of Two Fecal Biomarkers to Screen Children for IBD
This clinical trial update reports a head-to-head comparison of two fecal biomarkers to screen children for inflammatory bowel disease, with…
-
CLINICAL_TRIALS trial_result · 2017-05-04Clinical Trial Update: Oligofructose-enriched Inulin for the Treatment of Mild to Moderate Active Ulcerative Colitis [NA]
A completed clinical trial evaluated oligofructose-enriched inulin for the treatment of mild to moderate active ulcerative colitis, led by t…
-
CLINICAL_TRIALS trial_result · 2017-05-02Clinical Trial Update: Microbiota and Immune microEnvironment in Pouchitis [NA]
A clinical trial update detailing a study on the microbiota and immune microenvironment in pouchitis and related conditions.